| CDW |
Report |
Net sales / revenue |
BEAT |
pred ~$6.35B vs. cons ~$6.27B |
MEDIUM |
| CDW |
Report |
Non-GAAP EPS |
BEAT |
pred ~$2.87 vs. cons ~$2.82 |
MEDIUM |
| CDW |
Report |
Gross margin % |
MISS |
pred ~20.7% vs. cons ~21.0% |
MEDIUM |
| CDW |
Guide |
FY2026 non-GAAP EPS growth |
UNCHANGED |
guide ~7% vs. cons ~7% (FY2026) |
MEDIUM |
| CDW |
Guide |
H2 2026 revenue growth / demand normalization commentary |
UNCHANGED |
guide ~mid-single-digit vs. cons ~mid-single-digit (H2 2026) |
LOW |
| CDW |
Guide |
FY2026 gross margin (mix normalization) |
UNCHANGED |
guide ~21.0% (in-line w/ 2025) vs. cons ~21.0% (FY2026) |
MEDIUM |
| CDW |
Guide |
'Geared for Growth' SG&A savings run-rate ($100-200M by 2027-28) |
UNKNOWN |
guide ~$100-200M vs. cons ~no explicit Street figure, ~$150M implied midpoint (2027-2028) |
LOW |
| CDW |
Return |
Day-1 residual (stock − beta × S&P 500) |
+2.5% |
— |
MEDIUM |
| CDW |
Return |
5-day cumulative residual |
+0.3% (FADE) |
Q2 likely beats on hardware/backlog conversion (corroborated by TD Synnex/Connection prints), but management is expected to reiterate H2 caution rather than raise back-half estimates — meaning the 'improved outlook' stays 'steeped in Q2.' With the stock already up ~50% off May lows and ~10% in the past month pricing in a clean beat, any explicit or implicit signal that Q2 strength is pull-forward (tougher H2 comps, margin mix still hardware-heavy, netted-down recovery pushed later) triggers sell-the-news de-rating and modest downward revisions to H2/FY26 EPS as analysts true-up for magnitude of pull-forward, fading the initial pop over the week. |
MEDIUM |